ClassID:

20245

A61K31/20 - page 5 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Recent Application in this class:
#1201
20100099735
2010-04-22

METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION

#1202
20100098802
2010-04-22

MATRIX-EMBEDDED COMPOSITIONS HAVING ORGANIC ACIDS AND FATTY ACIDS

#1203
20100093855
2010-04-15

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#1204
20100076079
2010-03-25

Pharmaceutical compositions of short-acting sedative hypnotic agent

#1205
20100068313
2010-03-18

Cranberry seed oil extract and compositions containing components thereof

#1206
20100055202
2010-03-04

ANTIINFECTIVE FREE INTRAMAMMARY VETERINARY COMPOSITION

#1207
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#1208
20100041755
2010-02-18

Fatty acid treatment for cardiac patients

#1209
20100034873
2010-02-11

TRANSDERMAL RICINOLEIC ACID COMPOSITIONS

#1210
20100029973
2010-02-04

Fatty acid analogues for equilibrating bone mineral density

#1211
20100029557
2010-02-04

ALPHA-LACTALBUMIN COMPOSITION

#1212
20100022480
2010-01-28

Solid oral dosage form containing an enhancer

#1213
20100022444
2010-01-28

COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES

#1214
20100021573
2010-01-28

COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE

#1215
20100021555
2010-01-28

Compositions containing high omega-3 and low saturated fatty acid levels

#1216
20100021412
2010-01-28

REDUCTION OF HAIR GROWTH

#1217
20100015200
2010-01-21

Drug delivery medical device

#1218
20100010026
2010-01-14

Statin and omega-3 fatty acids for reduction of Apo-B levels

#1219
20100004338
2010-01-07

TOPICAL GEL COMPOSITION COMPRISING AZELAIC ACID

#1220
20100004310
2010-01-07

Pharmaceutical formulations for the treatment of alzheimer's disease

#1221
20090324636
2009-12-31

FISH OIL IN STABILIZED FORM

#1222
20090324518
2009-12-31

Novel Compositions Against Alkyl-Acyul-GPC The Derivatitves and Products Thereof

#1223
20090318384
2009-12-24

COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

#1224
20090317453
2009-12-24

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

#1225
20090312279
2009-12-17

Antimicrobial compositions

#1226
20090291102
2009-11-26

Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof

#1227
20090291066
2009-11-26

COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT

#1228
20090275670
2009-11-05

DOG PHEROMONE FORMULATION AND DELIVERY SYSTEM

#1229
20090275657
2009-11-05

Fatty acid antimicrobial

#1230
20090270504
2009-10-29

Treatment of Huntington's Disease With EPA

#1231
20090270502
2009-10-29

Method for Lowering Risk of Cardiovascular Diseases

#1232
20090270452
2009-10-29

USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS

#1233
20090264529
2009-10-22

Activators of peroxisome proliferator-activated receptors

#1234
20090264520
2009-10-22

LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF

#1235
20090257998
2009-10-15

METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS

#1236
20090253645
2009-10-08

METHODS AND MATERIALS FOR TREATING AND PREVENTING INFLAMMATION OF MUCOSAL TISSUE

#1237
20090252853
2009-10-08

Lipid Mixture and Use Thereof in the Preparation of a Product That Is Intended for Enteral or Oral Administration

#1238
20090252692
2009-10-08

Esterified fatty acid composition

#1239
20090247489
2009-10-01

Dihydroxyl compounds and compositions for cholesterol management and related uses

#1240
20090227677
2009-09-10

Low dose lipoic and pharmaceutical compositions and methods

#1241
20090226426
2009-09-10

Method for treating inflammation

#1242
20090215896
2009-08-27

REELIN DEFICIENCY OR DYSFUNCTION AND METHODS RELATED THERETO

#1243
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#1244
20090209601
2009-08-20

USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS

#1245
20090203783
2009-08-13

THERAPEUTIC AGENT FOR ACUTE CEREBRAL INFARCT

#1246
20090202657
2009-08-13

Methods and compositions for the prevention and treatment of inflammatory diseases

#1247
20090197849
2009-08-06

TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS

#1248
20090196920
2009-08-06

PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)

#1249
20090196918
2009-08-06

Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions

#1250
20090196917
2009-08-06

Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions

#1251
20090192201
2009-07-30

Composition and method for treating and preventing musculoskeletal and connective tissue disorders

#1252
20090192120
2009-07-30

INHIBITORS OF NITRIC OXIDE SYNTHASE

#1253
20090191245
2009-07-30

REDUCED-IRRITANT DERMATOLOGICAL COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOIC ACID COMPOUND AND BENZOYL PEROXIDE AND TREATMENT OF KERATINIZATION DISORDERS THEREWITH

#1254
20090186803
2009-07-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.

#1255
20090182054
2009-07-16

Topical compositions containing solubilized dicarboxylic acids

#1256
20090181893
2009-07-16

USE OF AGENTS THAT PREVENT GENERATION OF AMYLOID AND AMYLOID-LIKE LIPOPROTEINS, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT NEUROTOXICITY OF SUCH PROTEINS IN THE TREATMENT OF HEARING LOSS AND IMPROVING BODY BALANCE

#1257
20090181109
2009-07-16

Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases

#1258
20090169595
2009-07-02

Controlled release polymeric compositions of bone growth promoting compounds

#1259
20090156686
2009-06-18

Composition containing higher fatty acid derivative and foods and drinks

#1260
20090156487
2009-06-18

Infant nutritional compositions for preventing obesity

#1261
20090155186
2009-06-18

Compositions and methods for treating inflammatory conditions

#1262
20090153071
2009-06-18

Ignition circuit for igniting a discharge lamp and method for igniting the discharge lamp

#1263
20090149518
2009-06-11

PHARMACEUTICAL FOR PROTECTION OF MOTOR NERVE IN PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS

#1264
20090143467
2009-06-04

Anticancer agents based on regulation of protein prenylation

#1265
20090143277
2009-06-04

Nutritional composition for controlling blood sugar level

#1266
20090136615
2009-05-28

Nutrition with lipids and non-digestible saccharides

#1267
20090136539
2009-05-28

Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols

#1268
20090131523
2009-05-21

Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis

#1269
20090131302
2009-05-21

Transient receptor potential vanilloid 1 and uses thereof

#1270
20090124693
2009-05-14

Cosmetic Compositions Comprising Hydroxyfatty Acids

#1271
20090117203
2009-05-07

KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT

#1272
20090117194
2009-05-07

Eukaryotic Microorganisms for producing lipids and antioxidants

#1273
20090105342
2009-04-23

PUFA SUPPLEMENTS

#1274
20090088435
2009-04-02

Methods and compounds for treating retinol-related diseases

#1275
20090087484
2009-04-02

Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules

#1276
20090082455
2009-03-26

THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE

#1277
20090082283
2009-03-26

Dipeptides for prevention of muscle breakdown and microbial infection

#1278
20090069426
2009-03-12

Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid

#1279
20090068190
2009-03-12

ANTI-PROLIFERATIVE COMBINATIONS

#1280
20090060941
2009-03-05

Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols

#1281
20090054442
2009-02-26

METHOD OF ADMINISTERING OPHTHALMIC FLUIDS

#1282
20090048338
2009-02-19

Biologically active oils

#1283
20090048315
2009-02-19

Method of alleviating chronic pain via peripheral glutaminase regulation

#1284
20090042979
2009-02-12

Novel Statin Pharmaceutical Compositions and Related Methods of Treatment

#1285
20090036531
2009-02-05

Method for treatment of onychomycosis

#1286
20090036529
2009-02-05

(2R)-2-propyloctanoic acid for functional brain disease

#1287
20090036520
2009-02-05

Combinations of vasoprotective agents and formulations containing them

#1288
20090030078
2009-01-29

Therapeutic agent for pain

#1289
20090030055
2009-01-29

PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compounds

#1290
20090028930
2009-01-29

BRUISE AMELIORATION COMPOSITION AND METHOD OF USE

#1291
20090028904
2009-01-29

Novel cochleate formulations

#1292
20090023810
2009-01-22

METHODS OF TRANSLATION AND/OR INFLAMMATION BLOCKADE

#1293
20090022826
2009-01-22

Multi-step method of pain and/or inflammation treatment

#1294
20090022813
2009-01-22

Composition for improving membrane composition and functioning of cells

#1295
20090018199
2009-01-15

Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid

#1296
20090018186
2009-01-15

STABLE BEVERAGE PRODUCTS COMPRISING POLYUNSATURATED FATTY ACID EMULSIONS

#1297
20090017118
2009-01-15

COATED TABLETS, THEIR METHODS OF PREPARATION, AND RELATED USES

#1298
20090017057
2009-01-15

Stimulation of an immune response by cationic lipids

#1299
20090012166
2009-01-08

Oligomers of straight-chain and unbranched fatty acids and drugs containing these

#1300
20090012165
2009-01-08

PHARMACEUTICAL COMBINATION OF NSAID AND PROSTAGLANDIN COMPOUND

#1301
20090012136
2009-01-08

UNIT DOSE FORMULATIONS AND METHODS OF TREATING AND PREVENTING THROMBOSIS WITH THROMBOXANE RECEPTOR ANTAGONISTS

#1302
20090012115
2009-01-08

USE OF TP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS IN ASPIRIN SENSITIVE AND OTHER POPULATIONS

#1303
20090011042
2009-01-08

Antimicrobial and antiviral composition

#1304
20090010968
2009-01-08

Spot-on formulation useful for cosmetology and dermatology

#1305
20090005339
2009-01-01

Methods of treating ear infections

#1306
20090004305
2009-01-01

Antimicrobial and antiviral composition

#1307
20090004136
2009-01-01

Compounds to promote regeneration of bone marrow

#1308
20080317868
2008-12-25

Composition for improving membrane composition and functioning cells

#1309
20080317856
2008-12-25

Compositions Containing A Capillary -Active System With Application -Relevant Differentiability, And The Use Thereof

#1310
20080306157
2008-12-11

Therapeutic intervention to MIMIC the effect of caloric restriction

#1311
20080299187
2008-12-04

Substances for Reducing Occurence of Major Cardiac Events in Humans

#1312
20080293818
2008-11-27

Regulator of Physiological Function of Ghrelin and Use Thereof

#1313
20080292724
2008-11-27

COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS

#1314
20080292649
2008-11-27

Composition for improving membrane composition and functioning of cells

#1315
20080290328
2008-11-27

Photochromic material comprising a proteorhodopsin apoprotein and a retinal analog

#1316
20080279912
2008-11-13

Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders

#1317
20080275104
2008-11-06

METHODS OF TREATING JUVENILE TYPE 1 DIABETES MELLITUS

#1318
20080274203
2008-11-06

Bioeffective krill oil compositions

#1319
20080262077
2008-10-23

PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES

#1320
20080261922
2008-10-23

Pharmacological treatments for sleep disorders (apnoe) with prostanoid receptor antagonists

#1321
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#1322
20080260819
2008-10-23

SUSTAINED RELEASE COMPOSITIONS OF DRUGS

#1323
20080254010
2008-10-16

Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract

#1324
20080249166
2008-10-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#1325
20080234234
2008-09-25

Compounds to promote regeneration of bone marrow

#1326
20080220068
2008-09-11

TREATMENT AND PREVENTION OF EXCESSIVE SCARRING

#1327
20080214618
2008-09-04

Gastric Therapies Amd Compositions Therefor

#1328
20080213236
2008-09-04

Natural Remedy-Dietary Supplement Combination Product

#1329
20080213193
2008-09-04

Foam skin cream, uses of the foam skin protection cream and a process for its preparation

#1330
20080207756
2008-08-28

Bio-absorbable oil suspension

#1331
20080207748
2008-08-28

VITAMIN C PREPARATION

#1332
20080207745
2008-08-28

Orally-absorbed formulation for paromomycin

#1333
20080199923
2008-08-21

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#1334
20080199530
2008-08-21

ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

#1335
20080194518
2008-08-14

Antimicrobial Compositions

#1336
20080193561
2008-08-14

Preparation for the prevention and/or treatment of vascular disorders

#1337
20080188551
2008-08-07

Cosmetic composition comprising a lipid fraction from vegetable source and anticrystaling agent

#1338
20080182887
2008-07-31

Stable Oral Pharmaceutical Composition

#1339
20080181963
2008-07-31

Method for treatment of common acne

#1340
20080176954
2008-07-24

Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt

#1341
20080171790
2008-07-17

Fatty acids-systemic lipid solubilizers conjugates

#1342
20080171041
2008-07-17

METHOD FOR TREATING INFLAMMATION

#1343
20080167382
2008-07-10

Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases

#1344
20080166780
2008-07-10

Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids

#1345
20080166418
2008-07-10

KRILL OIL COMPOSITIONS

#1346
20080160007
2008-07-03

Diagnosis and treatment of cancer related to human dormancy

#1347
20080152710
2008-06-26

CO-BEADLET OF DHA AND ROSEMARY AND METHODS OF USE

#1348
20080152706
2008-06-26

Compositions containing coenzyme Q-10 and dihydrolipoic acid

#1349
20080139488
2008-06-12

Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea

#1350
20080132571
2008-06-05

Nutrient Sensor

#1351
20080131528
2008-06-05

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES

#1352
20080119553
2008-05-22

Activators of peroxisome proliferator-activated receptors

#1353
20080119552
2008-05-22

MATRIX-EMBEDDED COMPOSITIONS HAVING ORGANIC ACIDS AND FATTY ACIDS

#1354
20080114066
2008-05-15

Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function

#1355
20080114065
2008-05-15

Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology

#1356
20080107638
2008-05-08

Methods of attenuating autoimmune disease and compositions useful therefor

#1357
20080102131
2008-05-01

PARTICULATE COMPOSITION COMPRISING BIOACTIVE SUBSTANCE AND METHOD OF PRODUCING THE SAME

#1358
20080096963
2008-04-24

Use Of A Fatty Acid For Preparing A Topical Composition For Allaying Inflammatory Reaction Due To Vennemous Hymenoptera Strings

#1359
20080096910
2008-04-24

Rapid release mini-tablets provide analgesia in laboratory animals

#1360
20080096854
2008-04-24

Composition and method for treating or preventing gastrointestinal cancer

#1361
20080090848
2008-04-17

Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides

#1362
20080089945
2008-04-17

METHODS AND COMPOSITIONS FOR PROMOTING NORMAL CELL GROWTH AND INHIBITING CANCER CELL GROWTH

#1363
20080085911
2008-04-10

STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS

#1364
20080085322
2008-04-10

Methods and compositions for activating regenerative stem cells from bone marrow

#1365
20080081840
2008-04-03

Meal replacement compositions and weight control method

#1366
20080069774
2008-03-20

PROTEOMIC ANTISENSE MOLECULAR SHIELD AND TARGETING

#1367
20080064751
2008-03-13

Regulation of Phospholipase D Activity

#1368
20080064749
2008-03-13

Lipoxin Analogs as Novel Inhibitors of Angiogenesis

#1369
20080064661
2008-03-13

Dihydroxyl compounds and compositions for cholesterol management and related uses

#1370
20080064660
2008-03-13

Modulation of Inflammation Related to Columnar Epithelia

#1371
20080058418
2008-03-06

STABLE POLYUNSATURATED FATTY ACID EMULSIONS AND METHODS FOR INHIBITING, SUPPRESSING, OR REDUCING DEGRADATION OF POLYUNSATURATED FATTY ACIDS IN AN EMULSION

#1372
20080058416
2008-03-06

Cns Modulators

#1373
20080057115
2008-03-06

Capsule Stable Against Mastication

#1374
20080051454
2008-02-28

Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments

#1375
20080050455
2008-02-28

EQUINE GASTRIC ULCER THERAPY COMPOSITIONS AND EQUINE ULCER MANAGEMENT METHOD

#1376
20080050432
2008-02-28

Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors

#1377
20080032957
2008-02-07

Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers

#1378
20080020995
2008-01-24

Use of Cyclodextrin Complexes Containing Lipoic Acid

#1379
20080015166
2008-01-17

Barrier Integrity in Hiv Patients

#1380
20070293570
2007-12-20

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

#1381
20070292496
2007-12-20

Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics

#1382
20070281892
2007-12-06

Dopaminergic Mimetics

#1383
20070276039
2007-11-29

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

#1384
20070274935
2007-11-29

Method for treatment of onychomycosis

#1385
20070269507
2007-11-22

Type A gelatin capsule containing PUFA in free acid form

#1386
20070265196
2007-11-15

Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein

#1387
20070259037
2007-11-08

Method and composition for treatment of inflammatory conditions

#1388
20070258996
2007-11-08

Antimicrobial compositions

#1389
20070254043
2007-11-01

Sprayable beautifying composition

#1390
20070254026
2007-11-01

SOFTGEL CAPSULES

#1391
20070254014
2007-11-01

Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

#1392
20070238749
2007-10-11

Alpha2delta ligands for the treatment of fibromyalgia and other disorders

#1393
20070238707
2007-10-11

Solid oral dosage form containing an enhancer

#1394
20070237837
2007-10-11

BIOCOMPATIBLE TEA TREE OIL COMPOSITIONS

#1395
20070237836
2007-10-11

Strontium compound for treatment of sub-dermal soft tissue pain

#1396
20070231402
2007-10-04

Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof

#1397
20070231256
2007-10-04

Compositions and methods for detecting and treating tumors containing acidic areas

#1398
20070225368
2007-09-27

Therapy for multiple sclerosis

#1399
20070219270
2007-09-20

Medium chain fatty acids applicable as anti-microbial agents

#1400
20070219263
2007-09-20

Metronidazole/azelaic acid compositions for the treatment of rosacea

#1401
20070218113
2007-09-20

Health bars and compositions for improving cardiovascular risk factors

#1402
20070213401
2007-09-13

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

#1403
20070212339
2007-09-13

Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases

#1404
20070202194
2007-08-30

Preparation for the prevention and/or treatment of vascular disorders

#1405
20070196465
2007-08-23

Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof

#1406
20070196440
2007-08-23

Treatment methods requiring phyto-ingredients

#1407
20070185084
2007-08-09

COMPOSITIONS OF AN ANTICONVULSANT AND METHODS OF USING THE SAME FOR REVERSING WEIGHT GAIN

#1408
20070185038
2007-08-09

Regulation of mammalian keratinous tissue using skin care actives

#1409
20070184090
2007-08-09

PUFA supplements

#1410
20070179120
2007-08-02

Hydroxyl compounds and compositions for cholesterol management and related uses

#1411
20070166413
2007-07-19

Cholestrol-reducing agent containing an n-3 fatty acid

#1412
20070166374
2007-07-19

Composition and method for issue repair and regeneration

#1413
20070161707
2007-07-12

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

#1414
20070161706
2007-07-12

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

#1415
20070148643
2007-06-28

Treatment of Huntington's Disease with EPA

#1416
20070134349
2007-06-14

Methods of treating hematological malignancies

#1417
20070129430
2007-06-07

Agent for enhancing the production of collagen, their preparation and use

#1418
20070129317
2007-06-07

Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity

#1419
20070123588
2007-05-31

Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements

#1420
20070116778
2007-05-24

Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases

#1421
20070105957
2007-05-10

Methods and compositions for the treatment of asthma

#1422
20070105956
2007-05-10

Drug containing (2R)-2-propyloctanoic acid as the active ingredient

#1423
20070105788
2007-05-10

Azithromycin for treatment of granulomatous rosacea

#1424
20070099888
2007-05-03

Inflammation Inhibitor Comprising Zinc Salt of Acylamino Acid

#1425
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#1426
20070098808
2007-05-03

Krill extracts for treatment of cardiovascular diseases

#1427
20070098747
2007-05-03

Topical pharmaceutical composition for the treatment of inflammatory dermatoses

#1428
20070093552
2007-04-26

Early insulin secretion stimulator

#1429
20070087035
2007-04-19

Nutritional composition for wound healing

#1430
20070082384
2007-04-12

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#1431
20070066686
2007-03-22

Infusion preparation containing (2r)-2-propyloctanoic acid as at the active ingredient

#1432
20070065527
2007-03-22

Activated citrus peel extract

#1433
20070049569
2007-03-01

Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same

#1434
20070043116
2007-02-22

Method for preventing and/or treating neurodegenerative diseases

#1435
20070043114
2007-02-22

Nerve regeneration promoters

#1436
20070037887
2007-02-15

Blockade of mtor to prevent a hormonal adaptive response

#1437
20070037738
2007-02-15

Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions

#1438
20070036870
2007-02-15

Aiding of cognitive function

#1439
20070027212
2007-02-01

Alpha 2 delta ligands for post-traumatic stress disorder

#1440
20070027094
2007-02-01

Inhibitors of nitric oxide synthase to treat type 1 diabetes

#1441
20070026085
2007-02-01

Antimicrobial and antiviral composition

#1442
20070010459
2007-01-11

Application of asiatic acid and its derivatives to treat pulmonary fibrosis

#1443
20070004802
2007-01-04

Method for treating renal disease

#1444
20070004668
2007-01-04

Antisense permeation enhancers

#1445
20060286185
2006-12-21

Veterinary composition and method of using same

#1446
20060270739
2006-11-30

Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation

#1447
20060269551
2006-11-30

Method for treating inflammation

#1448
20060269496
2006-11-30

Reduction of hair growth

#1449
20060264411
2006-11-23

Control of biofilm formation

#1450
20060247310
2006-11-02

Body temperature elevating agents

#1451
20060233863
2006-10-19

Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy

#1452
20060229281
2006-10-12

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#1453
20060211768
2006-09-21

Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor

#1454
20060210659
2006-09-21

Anti-obesity agent

#1455
20060204518
2006-09-14

Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols

#1456
20060204517
2006-09-14

Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols

#1457
20060198898
2006-09-07

Method for preventing ulceration or irritation of mucosa

#1458
20060193895
2006-08-31

Additive for food and beverage, pharmaceutical composition, GLUT4 translocator, and method for translocating GLUT4

#1459
20060183799
2006-08-17

Biologically active oils

#1460
20060183797
2006-08-17

Fatty alcohols and fatty acid esters useful for treatment of inflammation

#1461
20060182819
2006-08-17

Soap scent patch and treatment for muscle spasm and pain

#1462
20060182818
2006-08-17

Transdermal patch and treatment for pain and discomfort

#1463
20060178347
2006-08-10

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

#1464
20060177920
2006-08-10

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#1465
20060165671
2006-07-27

Novel nutraceutical compositions comprising epigallocatechin gallate

#1466
20060160897
2006-07-20

Topical Use of Valproic Acid for the Prevention or Treatment of Skin Disorders

#1467
20060160750
2006-07-20

Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss

#1468
20060160203
2006-07-20

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#1469
20060159714
2006-07-20

Use of an antioxidant in a dermatological and/or cosmetic composition

#1470
20060153940
2006-07-13

Use of physiologically active fatty acids

#1471
20060153927
2006-07-13

Physiological tissue repair and functional organ regeneration by cultivation of regenerative stem cells in vivo and in situ

#1472
20060148732
2006-07-06

Inhibition of NF-kappaB by triterpene compositions

#1473
20060147405
2006-07-06

Method for treating urushiol induced contact dermatitis

#1474
20060142390
2006-06-29

Treatment for severe melancholic depression

#1475
20060142347
2006-06-29

Compounds and methods for the treatment or prevention of infections

#1476
20060128800
2006-06-15

Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

#1477
20060127450
2006-06-15

Composition containing higher fatty acid derivative and foods and drinks

#1478
20060122270
2006-06-08

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism

#1479
20060111329
2006-05-25

Anticancer agents based on regulation of protein prenylation

#1480
20060099248
2006-05-11

5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

#1481
20060094782
2006-05-04

Compositions and dosage forms for enhanced absorption

#1482
20060094669
2006-05-04

Method for treating bacterial infections in horses or pigs with tilmicosin

#1483
20060084637
2006-04-20

Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same

#1484
20060063838
2006-03-23

Activators of peroxisome proliferator-activated receptors

#1485
20060058387
2006-03-16

Composition and method for treating skin conditions

#1486
20060058225
2006-03-16

Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease

#1487
20060052451
2006-03-09

Method

#1488
20060052446
2006-03-09

Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders

#1489
20060052351
2006-03-09

Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress

#1490
20060051384
2006-03-09

Antiseptic compositions and methods of use

#1491
20060034815
2006-02-16

Statin pharmaceutical compositions and related methods of treatment

#1492
20060025478
2006-02-02

Medicine for prevention or treatment of diabetes

#1493
20060018938
2006-01-26

Foam skin cream, use of the foam skin protection cream and a process of its preparation

#1494
20060009521
2006-01-12

Lipoxin analogs as novel inhibitors of angiogenesis

#1495
20060008501
2006-01-12

Intraluminal device with a coating containing a therapeutic agent

#1496
20060004099
2006-01-05

Glycogen or polysaccharide storage disease treatment method

#1497
20060002874
2006-01-05

Topical pharmaceutical composition to treat hyperpigmentation of the skin

#1498
20050281748
2005-12-22

Abuse-deterrent drug formulations

#1499
20050277694
2005-12-15

Topical compositions and methods for epithelial-related conditions

#1500
20050272814
2005-12-08

Medicine for prevention or treatment of diabetes